Stockreport

Surrozen Provides Corporate Update on Clinical Programs [Yahoo! Finance]

Surrozen, Inc.  (SRZN) 
PDF - Completed enrollment for the Phase 1a clinical trial in chronic liver disease patients and healthy volunteers - Expect to announce Phase 1a safety and pharmacodynam [Read more]